Literature DB >> 30773345

Pharmacoepidemiological research for the development and evaluation of drugs in pediatrics.

Florentia Kaguelidou1, Geneviève Durrieu2, Antonio Clavenna3.   

Abstract

New regulations have come into force in Europe and the US establishing the pediatric development as an integral part of the early development of medicinal products. Parallel to the advances in pediatric clinical research, it became obvious that all available sources and research tools to gather valuable information for the safe and efficacious prescription of medicines in children should be used. Real-life, pharmacoepidemiological studies provide information that contribute to the better knowledge of drug utilization, effects and safety in the pediatric population and thereby, a better prescribing in children. In this paper, we suggest some possible applications, provide examples of impact of pharmacoepidemiological and pharmacovigilance studies and expose future perspectives in pediatric pharmacoepidemiology.
Copyright © 2019 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Challenges; Drug development; Pediatrics; Pharmacoepidemiology

Mesh:

Year:  2019        PMID: 30773345     DOI: 10.1016/j.therap.2018.09.077

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  1 in total

1.  Killing pain?: a population-based registry study of the use of prescription analgesics, anxiolytics, and hypnotics among all children, adolescents and young adults in Norway from 2004 to 2019.

Authors:  Helle Stangeland; Marte Handal; Svetlana Ondrasova Skurtveit; Helene Flood Aakvaag; Grete Dyb; Tore Wentzel-Larsen; Monica Baumann-Larsen; John Anker Zwart; Kjersti Storheim; Synne Øien Stensland
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-08-27       Impact factor: 5.349

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.